Literature DB >> 15126080

Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement.

Sharon M Weber1, Karen A Peterson, Benjamin Durkee, Chen Qi, Mark Longino, Thomas Warner, Fred T Lee, Jamey P Weichert.   

Abstract

INTRODUCTION: A major limitation in using both spontaneous and implanted murine liver tumor models in cancer research is the inability to accurately detect and monitor tumor volume. Because microCT without contrast enhancement cannot accurately distinguish tumor from normal liver, we sought to determine the accuracy of contrast enhanced microCT for monitoring liver tumors in mice, performed with intravenous (i.v.) injection of ITG, a hepatocyte-selective contrast agent.
METHODS: Twelve female BALB/c mice were injected with 5 x 10(5) CT26 tumor cells in two sites in the liver on day 0, resulting in 24 liver tumors. On days 3, 5, 7, and 10, three mice per day were injected with ITG (0.1 mL ITG/10 g body weight) by tail vein, followed 4 hours later by imaging with microCT (ImTek, Inc.). ITG is transported selectively to hepatocytes by an apoE receptor-mediated process that results in opacification of normal liver parenchyma after i.v. injection. Contrast enhancement on CT scans was graded as good, fair, or poor. After imaging, mice were euthanized to perform gross and histopathologic correlation of liver tumors with CT images.
RESULTS: The mean tumor size on microCT and at histopathologic evaluation was 2.2 and 2.3 mm, respectively (P > 0.05). Regression analysis showed no difference between the CT-measured tumor and the actual tumor size (P > 0.05). The overall accuracy for detection of tumor on microCT was 88%, with one false-positive and two false-negative readings. All three erroneous readings on CT scan occurred in mice in which the contrast enhancement of the liver was poor due to inadequate i.v. injection. Although the overall sensitivity and specificity was 90% and 75%, respectively, this was highly dependent on the degree of contrast enhancement.
CONCLUSIONS: MicroCT with ITG contrast is an excellent means to monitor tumor diameter in murine hepatic tumor models. However, adequate contrast enhancement is critical for accurate imaging.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126080     DOI: 10.1016/S0022-4804(03)00357-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

1.  Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Authors:  Lucia Martiniova; Susannah Cleary; Edwin W Lai; Dale O Kiesewetter; Jurgen Seidel; Linda F Dawson; Jacqueline K Phillips; David Thomasson; Xiaoyuan Chen; Graeme Eisenhofer; James F Powers; Richard Kvetnansky; Karel Pacak
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

2.  Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC.

Authors:  Inneke Willekens; Tony Lahoutte; Nico Buls; Christian Vanhove; Rudi Deklerck; Axel Bossuyt; Johan de Mey
Journal:  Mol Imaging Biol       Date:  2008-12-06       Impact factor: 3.488

Review 3.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

Review 4.  Using Nanoparticles in Medicine for Liver Cancer Imaging.

Authors:  Farideh Farokhi Moghadam
Journal:  Oman Med J       Date:  2017-07

5.  Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.

Authors:  Ki Young Choi; Eun Jung Jeon; Hong Yeol Yoon; Beom Suk Lee; Jin Hee Na; Kyung Hyun Min; Sang Yoon Kim; Seung-Jae Myung; Seulki Lee; Xiaoyuan Chen; Ick Chan Kwon; Kuiwon Choi; Seo Young Jeong; Kwangmeyung Kim; Jae Hyung Park
Journal:  Biomaterials       Date:  2012-06-09       Impact factor: 12.479

Review 6.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

Review 7.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

8.  A microcomputed tomography guided fluorescence tomography system for small animal molecular imaging.

Authors:  Dax Kepshire; Niculae Mincu; Michael Hutchins; Josiah Gruber; Hamid Dehghani; Justin Hypnarowski; Frederic Leblond; Mario Khayat; Brian W Pogue
Journal:  Rev Sci Instrum       Date:  2009-04       Impact factor: 1.523

9.  In vivo assessment of printed microvasculature in a bilayer skin graft to treat full-thickness wounds.

Authors:  Maria Yanez; Julio Rincon; Aracely Dones; Carmelo De Maria; Raoul Gonzales; Thomas Boland
Journal:  Tissue Eng Part A       Date:  2014-09-03       Impact factor: 3.845

10.  Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.

Authors:  Christopher C Riedl; Peter Brader; Pat Zanzonico; Vincent Reid; Yanghee Woo; Bixiu Wen; C Clifton Ling; Hedvig Hricak; Yuman Fong; John L Humm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.